Serum resistin and hepatic fat content in nondiabetic individuals

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 12, 2006, Pages 5122-5125

  Perseghin, Gianluca ^a,b   Lattuada, Guido ^a   De Cobelli, Francesco ^a   Ntali, Georgia ^a,c,d   Esposito, Antonio ^a   Burska, Agata ^a,e   Belloni, Elena ^a   Canu, Tamara ^a   Ragogna, Francesca ^a   Scifo, Paola ^a   Del Maschio, Alessandro ^a   Luzi, Livio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Polikliniki Hospital   (Greece)

^d HAROKOPIO UNIVERSITY   (Greece)

^e Medicinal University of Lublin   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FAT CONTENT; FEMALE; GASTROCNEMIUS MUSCLE; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID STORAGE; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

EID: 33845491270     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1368     Document Type: Article

References (20)

1. Steppan CM, Bailey ST, Baht S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, LazarMA2001 The hormone resistin links obesity to diabetes. Nature 409:307-312
2. Arner P 2005 Resistin: yet another adipokine tells us that men are not mice. Diabetologia 48:2203-2205
3. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A 2005 Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795
4. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, Avellini C, Federspil G, Sechi LA, Vettor R 2006 Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 91:1081-1086
5. Neuschwander-Tetri BA, Caldwell SH 2003 Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202-1219
6. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Ragogna F, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L 2005 Reduced intra-hepatic fat content is associated with increased whole body lipid oxidation in patients with type 1 diabetes. Diabetologia 48:2615-2621
7. Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, Chiumello G, Luzi L 2006 Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 10.1152/ajpendo. 00017
8. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L 1999 Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13CNMRspectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606
9. Perseghin G, Burska A, Lattuada G, Alberti G, Costantino F, Ragogna F, Oggionni S, Scollo A, Terruzzi I, Luzi L 2006 Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 49:1893-1900
10. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
11. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850
12. Longo R, Ricci C, Masutti F, Vidimari R, Croce LS, Bercich L, Tiribelli C, Dalla Palma L 1993 Fatty infiltration of the liver quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 28:297-302
13. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL 2004 Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
14. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H 2002 Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity an normal men. J Clin Endocrinol Metab 87:3023-3028
15. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI 2005 Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603-608
16. Bajaj M, Suraamornkul, Hardies LJ, Pratipanawatr T, DeFronzo RA 2004 Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes 28:783-789
17. Carey AL, Wolsk Petersen E, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA 2006 Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49:1000-1007
18. Adams LA, Lymp JF, Sauver JS, Sanderson SO, Lindor KD, Feldstein A, Angulo P 2005 The natural history of nonalcoholic fatty liver disease: a population-based study. Gastroenterology 129:113-121
19. Diehl AM 2002 Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282:G1-G5
20. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G 2005 Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504